// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Normothermic Ex Vivo Liver Perfusion Prior to Liver Transplantation Can Prevent Platelet Aggregation and Platelet Induced Sinusoidal Cell Injury

D. Kollmann - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

Hyaluronic acid

Normothermic Ex-Vivo Kidney Perfusion Restores the Genetic Profile of Marginal Kidney Grafts Subjected to Warm Ischemia

P. Urbanellis - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Opting out and Offers of 'Alibis' for Potential Living Kidney Donors in the US

R. Iskander - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Outcome Implications of Benzodiazepines and Opioid Co-Prescriptions before Kidney Transplantation

N. Lam - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Epimorph

Outcomes of Transplant Patients with Encapsulating Peritoneal Sclerosis(EPS) Treated with Tamoxifen and Steroids

R. Parthasarathy - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

Icodextrin

Pancreas Transplant for Type 2 Diabetes is Associated with Preserved Function, but Impaired Glucose Tolerance: A Comparative Analysis

S. Doshi - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Pancreatic Graft Loss after Simultaneous Pancreas Kidney (SPK) Transplant within First 90 Days. Predictors beyond the Surgical Cause. A UNOS/OPTN Data Analysis

H. Sharma - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Participation in Paid Work across the Transplant Trajectory from the Perspective of End-Stage-Kidney-Disease Patients

K. Gaudet - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

Patient-Researcher Partnership Platform within the Canadian National Transplant Research Program: The First Year Experience

M-.C. Fortin - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pattern of Respiratory Virus Infection (RVI) and Chronic Lung Allograft Dysfunction (CLAD) in Lung Transplant Recipients (LTR)

L. Somerville - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Peri-Operative Hemoglobin, Blood Transfusion and Delayed Graft Function in Kidney Transplant Recipients

S. MacIsaac - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

Persistent Progressive Acute Kidney Injury and Graft Failure Post Liver Transplantation

T. Hussaini - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

Postâ€Donation eGFR Levels Predicts Newâ€Onset Antihypertensive Medication Use after Living Kidney Donation

K. Lentine - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Predictors of Graft Survival at the Time of a Kidney Transplant Indication Biopsy

G. Einecke - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Prevalence and Infection-Related Outcomes Associated with Transplant Tourism

J. Slomovic - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Promoting Medication Adherence from the Perspectives of Teen and Young Adult Kidney Recipients, Parents and Health Care Professionals

C. Nguyen - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Prospective, Multi-Center Observational Study of Cell-Mediated Immunity for Cytomegalovirus Infection in Kidney Transplant Recipients

D. Kumar - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

N/A

Protocol Biopsies after Paediatric Kidney Transplantation: A Single Centres' 17 Year Experience

T. Alsulaimi - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

QPI-1002, a siRNA Targeting p53: Improvement in Outcomes Following Acute Kidney Injury (AKI): Cardiac Surgery to AKI Donors

J. Tchervenkov - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

QPI 1002

Regulation of NK Cell Cytotoxicity by TEC Expression of Clr Proteins in Kidney Ischemia Reperfusion Injury (IRI)

B. Fuhrmann - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved